Global Tumor Ablation Devices Market
Global Tumor Ablation Devices Market

Tumor Ablation Devices Comprehensive Study by Type (Thermal (Electrical, Radiation, Radiofrequency, Light, Ultrasound, Microwave, and Hydrothermal Ablation), Non-Thermal (Cryoablation, Hydromechanical Ablation)), Application (Cancer, Cardiovascular, Ophthalmology, Gynecology, Urology, Orthopedics), Functions (Automated, Robotic, Conventional) Players and Region - Global Market Outlook to 2025

Tumor Ablation Devices Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Jan 2020 Edition 203 Pages 212 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Tumor Ablation Devices Market Overview:
The term tumor ablation is defined as the direct application of chemical non-energy or energy-based such as thermal and non-thermal therapies to eradicate or substantially destroy focal tumors. The term direct aims to distinguish these often applicator-based therapies from others that are applied orally or via an intravascular or peripheral venous route. Various thermal ablation includes RF, Microwave, Ultrasound and others.

Market Drivers
  • Increasing Occurrence of Chronic Diseases
  • Growing Use of RF Ablation Catheter Devices

Market Trend
  • Technological Development in Tumor Ablation such as Cryoablation Balloon Catheters

Restraints
  • High Cost Related to Tumor Ablation Devices

Opportunities
  • Growing Awareness about the Benefits of Ablation Techniques


Competitive Landscape:

Some of the key players profiled in the report are St. Jude Medical, Inc. (United States), Medtronic plc (Ireland), Boston Scientific Corporation (United States), AngioDynamics, Inc. (United States), AtriCure, Inc. (United States), Conmed Corporation (United States), Smith & Nephew plc (United Kingdom), BTG plc (United Kingdom), Johnson & Johnson (United States), C.R. Bard, Inc. (United States), Elekta AB (Sweden), Hologic, Inc. (United States), Stryker Corporation (United States) and EDAP TMS S.A. (France). Additionally, following companies can also be profiled that are part of our coverage like Misonix, Inc. (United States) and Olympus Corporation (Japan). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Tumor Ablation Devices market by 2025. Considering Market by Functions, the sub-segment i.e. Automated will boost the Tumor Ablation Devices market.

Market Highlights:
On January 8, 2020 - Medtronic plc, announced that it has acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed Spinal Cord Stimulation.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Tumor Ablation Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Tumor Ablation Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Tumor Ablation Devices, Suppliers of Tumor Ablation Devices, Wholesalers, Distributors and Retailers of Tumor Ablation Devices, Healthcare Industry and Governmental Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Thermal [Electrical, Radiation, Radiofrequency, Light, Ultrasound, Microwave, and Hydrothermal Ablation]
  • Non-Thermal [Cryoablation, Hydromechanical Ablation]
By Application
  • Cancer
  • Cardiovascular
  • Ophthalmology
  • Gynecology
  • Urology
  • Orthopedics
By Functions
  • Automated
  • Robotic
  • Conventional

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Occurrence of Chronic Diseases
      • 3.2.2. Growing Use of RF Ablation Catheter Devices
    • 3.3. Market Trends
      • 3.3.1. Technological Development in Tumor Ablation such as Cryoablation Balloon Catheters
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Tumor Ablation Devices, by Type, Application, Functions and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Tumor Ablation Devices (Volume)
      • 5.2.1. Global Tumor Ablation Devices by: Type (Volume)
        • 5.2.1.1. Thermal [Electrical, Radiation, Radiofrequency, Light, Ultrasound, Microwave, and Hydrothermal Ablation]
        • 5.2.1.2. Non-Thermal [Cryoablation, Hydromechanical Ablation]
      • 5.2.2. Global Tumor Ablation Devices by: Application (Volume)
        • 5.2.2.1. Cancer
        • 5.2.2.2. Cardiovascular
        • 5.2.2.3. Ophthalmology
        • 5.2.2.4. Gynecology
        • 5.2.2.5. Urology
        • 5.2.2.6. Orthopedics
      • 5.2.3. Global Tumor Ablation Devices by: Functions (Volume)
        • 5.2.3.1. Automated
        • 5.2.3.2. Robotic
        • 5.2.3.3. Conventional
      • 5.2.4. Global Tumor Ablation Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Tumor Ablation Devices (Price)
      • 5.3.1. Global Tumor Ablation Devices by: Type (Price)
  • 6. Tumor Ablation Devices: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. St. Jude Medical, Inc. (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Medtronic plc (Ireland)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Boston Scientific Corporation (United States)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. AngioDynamics, Inc. (United States)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. AtriCure, Inc. (United States)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Conmed Corporation (United States)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Smith & Nephew plc (United Kingdom)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. BTG plc (United Kingdom)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Johnson & Johnson (United States)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. C.R. Bard, Inc. (United States)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
      • 6.1.11. Elekta AB (Sweden)
        • 6.1.11.1. Business Overview
        • 6.1.11.2. Products/Services Offerings
        • 6.1.11.3. Financial Analysis
        • 6.1.11.4. SWOT Analysis
      • 6.1.12. Hologic, Inc. (United States)
        • 6.1.12.1. Business Overview
        • 6.1.12.2. Products/Services Offerings
        • 6.1.12.3. Financial Analysis
        • 6.1.12.4. SWOT Analysis
      • 6.1.13. Stryker Corporation (United States)
        • 6.1.13.1. Business Overview
        • 6.1.13.2. Products/Services Offerings
        • 6.1.13.3. Financial Analysis
        • 6.1.13.4. SWOT Analysis
      • 6.1.14. EDAP TMS S.A. (France)
        • 6.1.14.1. Business Overview
        • 6.1.14.2. Products/Services Offerings
        • 6.1.14.3. Financial Analysis
        • 6.1.14.4. SWOT Analysis
  • 7. Global Tumor Ablation Devices Sale, by Type, Application, Functions and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Tumor Ablation Devices (Volume)
      • 7.2.1. Global Tumor Ablation Devices by: Type (Volume)
        • 7.2.1.1. Thermal [Electrical, Radiation, Radiofrequency, Light, Ultrasound, Microwave, and Hydrothermal Ablation]
        • 7.2.1.2. Non-Thermal [Cryoablation, Hydromechanical Ablation]
      • 7.2.2. Global Tumor Ablation Devices by: Application (Volume)
        • 7.2.2.1. Cancer
        • 7.2.2.2. Cardiovascular
        • 7.2.2.3. Ophthalmology
        • 7.2.2.4. Gynecology
        • 7.2.2.5. Urology
        • 7.2.2.6. Orthopedics
      • 7.2.3. Global Tumor Ablation Devices by: Functions (Volume)
        • 7.2.3.1. Automated
        • 7.2.3.2. Robotic
        • 7.2.3.3. Conventional
      • 7.2.4. Global Tumor Ablation Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Tumor Ablation Devices (Price)
      • 7.3.1. Global Tumor Ablation Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Tumor Ablation Devices Sales: by Type(K Units)
  • Table 2. Tumor Ablation Devices Sales Thermal [Electrical, Radiation, Radiofrequency, Light, Ultrasound, Microwave, and Hydrothermal Ablation] , by Region K Units (2014-2019)
  • Table 3. Tumor Ablation Devices Sales Non-Thermal [Cryoablation, Hydromechanical Ablation] , by Region K Units (2014-2019)
  • Table 4. Tumor Ablation Devices Sales: by Application(K Units)
  • Table 5. Tumor Ablation Devices Sales Cancer , by Region K Units (2014-2019)
  • Table 6. Tumor Ablation Devices Sales Cardiovascular , by Region K Units (2014-2019)
  • Table 7. Tumor Ablation Devices Sales Ophthalmology , by Region K Units (2014-2019)
  • Table 8. Tumor Ablation Devices Sales Gynecology , by Region K Units (2014-2019)
  • Table 9. Tumor Ablation Devices Sales Urology , by Region K Units (2014-2019)
  • Table 10. Tumor Ablation Devices Sales Orthopedics , by Region K Units (2014-2019)
  • Table 11. Tumor Ablation Devices Sales: by Functions(K Units)
  • Table 12. Tumor Ablation Devices Sales Automated , by Region K Units (2014-2019)
  • Table 13. Tumor Ablation Devices Sales Robotic , by Region K Units (2014-2019)
  • Table 14. Tumor Ablation Devices Sales Conventional , by Region K Units (2014-2019)
  • Table 15. South America Tumor Ablation Devices Sales, by Country K Units (2014-2019)
  • Table 16. South America Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 17. South America Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 18. South America Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 19. Brazil Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 20. Brazil Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 21. Brazil Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 22. Argentina Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 23. Argentina Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 24. Argentina Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 25. Rest of South America Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 26. Rest of South America Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 27. Rest of South America Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 28. Asia Pacific Tumor Ablation Devices Sales, by Country K Units (2014-2019)
  • Table 29. Asia Pacific Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 30. Asia Pacific Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 31. Asia Pacific Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 32. China Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 33. China Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 34. China Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 35. Japan Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 36. Japan Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 37. Japan Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 38. India Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 39. India Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 40. India Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 41. South Korea Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 42. South Korea Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 43. South Korea Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 44. Taiwan Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 45. Taiwan Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 46. Taiwan Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 47. Australia Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 48. Australia Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 49. Australia Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 50. Rest of Asia-Pacific Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 51. Rest of Asia-Pacific Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 52. Rest of Asia-Pacific Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 53. Europe Tumor Ablation Devices Sales, by Country K Units (2014-2019)
  • Table 54. Europe Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 55. Europe Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 56. Europe Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 57. Germany Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 58. Germany Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 59. Germany Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 60. France Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 61. France Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 62. France Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 63. Italy Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 64. Italy Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 65. Italy Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 66. United Kingdom Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 67. United Kingdom Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 68. United Kingdom Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 69. Netherlands Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 70. Netherlands Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 71. Netherlands Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 72. Rest of Europe Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 73. Rest of Europe Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 74. Rest of Europe Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 75. MEA Tumor Ablation Devices Sales, by Country K Units (2014-2019)
  • Table 76. MEA Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 77. MEA Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 78. MEA Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 79. Middle East Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 80. Middle East Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 81. Middle East Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 82. Africa Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 83. Africa Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 84. Africa Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 85. North America Tumor Ablation Devices Sales, by Country K Units (2014-2019)
  • Table 86. North America Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 87. North America Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 88. North America Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 89. United States Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 90. United States Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 91. United States Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 92. Canada Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 93. Canada Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 94. Canada Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 95. Mexico Tumor Ablation Devices Sales, by Type K Units (2014-2019)
  • Table 96. Mexico Tumor Ablation Devices Sales, by Application K Units (2014-2019)
  • Table 97. Mexico Tumor Ablation Devices Sales, by Functions K Units (2014-2019)
  • Table 98. Tumor Ablation Devices: by Type(USD/Units)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Tumor Ablation Devices Sales: by Type(K Units)
  • Table 114. Tumor Ablation Devices Sales Thermal [Electrical, Radiation, Radiofrequency, Light, Ultrasound, Microwave, and Hydrothermal Ablation] , by Region K Units (2020-2025)
  • Table 115. Tumor Ablation Devices Sales Non-Thermal [Cryoablation, Hydromechanical Ablation] , by Region K Units (2020-2025)
  • Table 116. Tumor Ablation Devices Sales: by Application(K Units)
  • Table 117. Tumor Ablation Devices Sales Cancer , by Region K Units (2020-2025)
  • Table 118. Tumor Ablation Devices Sales Cardiovascular , by Region K Units (2020-2025)
  • Table 119. Tumor Ablation Devices Sales Ophthalmology , by Region K Units (2020-2025)
  • Table 120. Tumor Ablation Devices Sales Gynecology , by Region K Units (2020-2025)
  • Table 121. Tumor Ablation Devices Sales Urology , by Region K Units (2020-2025)
  • Table 122. Tumor Ablation Devices Sales Orthopedics , by Region K Units (2020-2025)
  • Table 123. Tumor Ablation Devices Sales: by Functions(K Units)
  • Table 124. Tumor Ablation Devices Sales Automated , by Region K Units (2020-2025)
  • Table 125. Tumor Ablation Devices Sales Robotic , by Region K Units (2020-2025)
  • Table 126. Tumor Ablation Devices Sales Conventional , by Region K Units (2020-2025)
  • Table 127. South America Tumor Ablation Devices Sales, by Country K Units (2020-2025)
  • Table 128. South America Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 129. South America Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 130. South America Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 131. Brazil Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 132. Brazil Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 133. Brazil Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 134. Argentina Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 135. Argentina Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 136. Argentina Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 137. Rest of South America Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 138. Rest of South America Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 139. Rest of South America Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 140. Asia Pacific Tumor Ablation Devices Sales, by Country K Units (2020-2025)
  • Table 141. Asia Pacific Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 142. Asia Pacific Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 143. Asia Pacific Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 144. China Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 145. China Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 146. China Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 147. Japan Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 148. Japan Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 149. Japan Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 150. India Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 151. India Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 152. India Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 153. South Korea Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 154. South Korea Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 155. South Korea Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 156. Taiwan Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 157. Taiwan Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 158. Taiwan Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 159. Australia Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 160. Australia Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 161. Australia Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 162. Rest of Asia-Pacific Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 163. Rest of Asia-Pacific Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 164. Rest of Asia-Pacific Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 165. Europe Tumor Ablation Devices Sales, by Country K Units (2020-2025)
  • Table 166. Europe Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 167. Europe Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 168. Europe Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 169. Germany Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 170. Germany Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 171. Germany Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 172. France Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 173. France Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 174. France Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 175. Italy Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 176. Italy Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 177. Italy Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 178. United Kingdom Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 179. United Kingdom Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 180. United Kingdom Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 181. Netherlands Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 182. Netherlands Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 183. Netherlands Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 184. Rest of Europe Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 185. Rest of Europe Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 186. Rest of Europe Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 187. MEA Tumor Ablation Devices Sales, by Country K Units (2020-2025)
  • Table 188. MEA Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 189. MEA Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 190. MEA Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 191. Middle East Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 192. Middle East Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 193. Middle East Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 194. Africa Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 195. Africa Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 196. Africa Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 197. North America Tumor Ablation Devices Sales, by Country K Units (2020-2025)
  • Table 198. North America Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 199. North America Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 200. North America Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 201. United States Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 202. United States Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 203. United States Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 204. Canada Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 205. Canada Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 206. Canada Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 207. Mexico Tumor Ablation Devices Sales, by Type K Units (2020-2025)
  • Table 208. Mexico Tumor Ablation Devices Sales, by Application K Units (2020-2025)
  • Table 209. Mexico Tumor Ablation Devices Sales, by Functions K Units (2020-2025)
  • Table 210. Tumor Ablation Devices: by Type(USD/Units)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Tumor Ablation Devices: by Type K Units (2014-2019)
  • Figure 5. Global Tumor Ablation Devices: by Application K Units (2014-2019)
  • Figure 6. Global Tumor Ablation Devices: by Functions K Units (2014-2019)
  • Figure 7. South America Tumor Ablation Devices Share (%), by Country
  • Figure 8. Asia Pacific Tumor Ablation Devices Share (%), by Country
  • Figure 9. Europe Tumor Ablation Devices Share (%), by Country
  • Figure 10. MEA Tumor Ablation Devices Share (%), by Country
  • Figure 11. North America Tumor Ablation Devices Share (%), by Country
  • Figure 12. Global Tumor Ablation Devices: by Type USD/Units (2014-2019)
  • Figure 13. St. Jude Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 14. St. Jude Medical, Inc. (United States) Revenue: by Geography 2019
  • Figure 15. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 16. Medtronic plc (Ireland) Revenue: by Geography 2019
  • Figure 17. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Boston Scientific Corporation (United States) Revenue: by Geography 2019
  • Figure 19. AngioDynamics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. AngioDynamics, Inc. (United States) Revenue: by Geography 2019
  • Figure 21. AtriCure, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. AtriCure, Inc. (United States) Revenue: by Geography 2019
  • Figure 23. Conmed Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Conmed Corporation (United States) Revenue: by Geography 2019
  • Figure 25. Smith & Nephew plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Smith & Nephew plc (United Kingdom) Revenue: by Geography 2019
  • Figure 27. BTG plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. BTG plc (United Kingdom) Revenue: by Geography 2019
  • Figure 29. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 30. Johnson & Johnson (United States) Revenue: by Geography 2019
  • Figure 31. C.R. Bard, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. C.R. Bard, Inc. (United States) Revenue: by Geography 2019
  • Figure 33. Elekta AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 34. Elekta AB (Sweden) Revenue: by Geography 2019
  • Figure 35. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Hologic, Inc. (United States) Revenue: by Geography 2019
  • Figure 37. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Stryker Corporation (United States) Revenue: by Geography 2019
  • Figure 39. EDAP TMS S.A. (France) Revenue, Net Income and Gross profit
  • Figure 40. EDAP TMS S.A. (France) Revenue: by Geography 2019
  • Figure 41. Global Tumor Ablation Devices: by Type K Units (2020-2025)
  • Figure 42. Global Tumor Ablation Devices: by Application K Units (2020-2025)
  • Figure 43. Global Tumor Ablation Devices: by Functions K Units (2020-2025)
  • Figure 44. South America Tumor Ablation Devices Share (%), by Country
  • Figure 45. Asia Pacific Tumor Ablation Devices Share (%), by Country
  • Figure 46. Europe Tumor Ablation Devices Share (%), by Country
  • Figure 47. MEA Tumor Ablation Devices Share (%), by Country
  • Figure 48. North America Tumor Ablation Devices Share (%), by Country
  • Figure 49. Global Tumor Ablation Devices: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • St. Jude Medical, Inc. (United States)
  • Medtronic plc (Ireland)
  • Boston Scientific Corporation (United States)
  • AngioDynamics, Inc. (United States)
  • AtriCure, Inc. (United States)
  • Conmed Corporation (United States)
  • Smith & Nephew plc (United Kingdom)
  • BTG plc (United Kingdom)
  • Johnson & Johnson (United States)
  • C.R. Bard, Inc. (United States)
  • Elekta AB (Sweden)
  • Hologic, Inc. (United States)
  • Stryker Corporation (United States)
  • EDAP TMS S.A. (France)
Additional players considered in the study are as follows:
Misonix, Inc. (United States) , Olympus Corporation (Japan)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation